ADC	Antibody drug conjugate
ADCC	Antibody-dependent cellular cytotoxicity
AF-HPA	Auristatin F-hydroxypropylamide
BCN	Bicyclononyme
β-Me	2-mercaptoethanol
DDS	Drug delivery system
DENC	Double emulsion nanocapsule
DTT	Dithiothreitol
EBC	Early breast cancer
EDC	1-ethyl-3-(3-dimethylaminopropyl)
EGFR	Epidermal growth factor receptor
EMA	European Medicines Agency
EPR	Enhanced permeability and retention
FDA	U.S. Food and Drug Administration
GMBS	4-maleimidobutyric acid-N hydroxysuccinimide
GSH	Glutathione
HER	Human epithermal growth factor receptor
HSA	Human serum albumin
IgG	Immunoglobulin
MBC	Metastatic breast cancer
MDR	Multidrug resistance
MMA	Monomethyl auristatin
MRI	Magnetic resonance imaging
MTT	Montmorillonite
MTX	Methotrexate
NGM	Next-generation maleimide
NHS	N-hydroxysulfosuccinimide
NPs	Nanoparticles
NSCLC	Non-small cell lung carcinoma
PBD-MA	Pyrrolo[2,1-c][1,4]benzodiazepine monoamide
PD	Pyridazinedione
PEG	Polyethylene glycol
PEI	Polyethylenimine
PET	Positron Emission Tomography
Phis	Poly-L-histidine
PLA	Polylactide
PLGA	Poly(lactic-co-glycolic acid)
PPɣ	Polypyrrole
SMCC	Succinimidyl-4-(N-maleimidomethyl)-cyclohexane-1-carboxylate
TCEP	Tris-2-carboxyethylphosphine
TCO	Trans-cyclooctene
THP	Tumor homing peptide
TKI	Tyrosine-kinase inhibitor
Tmab	Trastuzumab
TPGS	Tocopheryl polyethylene glycol succinate
Tz	1,2,4,5-tetrazine
VEGFR	Vascular endothelial growth factor receptor
WHO	World Health Organization